Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-small cell lung cancer: A sequential model

BACKGROUND: A total of 11 treatment sequences for advanced wild-type squamous non-small cell lung cancer are recommended by Chinese Society of Clinical Oncology Guidelines, consisting of seven first-line and three second-line treatments. Five of these treatments were newly approved in China between...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Mingye, Shao, Taihang, Chi, Zhuoyuan, Tang, Wenxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999022/
https://www.ncbi.nlm.nih.gov/pubmed/36908446
http://dx.doi.org/10.3389/fpubh.2023.1051484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999022/
https://www.ncbi.nlm.nih.gov/pubmed/36908446
http://dx.doi.org/10.3389/fpubh.2023.1051484

Ejemplares similares